Drug intelligence / Profile preview

Obimin-AZ

Development stage: Unknown
Lead developer: Great Eastern Drug Co.
Modality: Small Molecules
Administration: Oral

Overview

Obimin-AZ is an oral prenatal multivitamin and mineral supplement developed by Great Eastern Drug. It is formulated specifically to prevent and treat vitamin and mineral deficiencies in women during pregnancy, the postpartum period, and lactation, as well as in postmenopausal women and the elderly. Each tablet contains a comprehensive blend of essential nutrients, including vitamins A, D, E, C, and B-complex (B1, B2, B3/nicotinamide, B6, B12), folic acid, ferrous fumarate (iron), calcium lactate, potassium iodate (iodine), and zinc sulfate. This combination supports maternal health, fetal development, and helps prevent conditions such as iron-deficiency anemia.

Brand names: Obimin-AZ
Other names: iron + multivitamins + mineralsmultivitamins + minerals

Beyond the preview

Go deeper on Obimin-AZ.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Obimin-AZ.

Explore the full profile